| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000032421 |
| Receipt No. | R000036723 |
| Official scientific title of the study | Investigation of involvement of oxidative stress and glycative stress in patients with cardiovascular disease |
| Date of disclosure of the study information | 2018/05/30 |
| Last modified on | 2018/04/28 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Investigation of involvement of oxidative stress and glycative stress in patients with cardiovascular disease | |
| Title of the study (Brief title) | Investigation of involvement of oxidative stress and glycative stress in patients with cardiovascular disease | |
| Region |
|
|
| Condition | |||
| Condition | cardiovascular disease | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the involvement of oxidative stress and glycative stress in cardiovascular disease patients by simultaneously measuring urine 8 - OHdG and AGEs accumulation in skin or subcutaneous tissue |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Major cardiovascular events (acute coronary syndrome, revascularization, heart failure, stroke, other hospitalization), death
occurring one year and three years later |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who understand this study and obtained document agreement by intention of patient themselves | |||
| Key exclusion criteria | 1.Patients with severe complications that are problematic when participating in this study, such as amputation of limbs, severe skin complications
2.Patients judged that examination responsibility doctor is improper as object in present study |
|||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Kazunori Shimada |
| Organization | Juntendo University, Graduate School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | 2-1-1 Hongo,Bunkyo-ku Tokyo Japan |
| TEL | 03-3813-3111 |
| shimakaz@juntendo.ac.jp | |
| Public contact | |
| Name of contact person | Miho Yokoyama |
| Organization | Juntendo University, Graduate School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | Department of Cardiovascular Medicine |
| TEL | 03-3813-3111 |
| Homepage URL | |
| mipocch@juntendo.ac.jp | |
| Sponsor | |
| Institute | Juntendo University, Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Juntendo University, Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective observational study.
<Study subjects> The patients with cardiovascular disease who are visiting or hospitalized for Juntendo University Hospital, Department of Cardiology are targeted. 1 Coronary artery disease 2 Valvular disease 3 Heart failure 4 Arrhythmia 5 Aortic disease 6 Peripheral artery disease 7 Cerebrovascular disease |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036723 |